Pharmacological mTOR inhibitors have emerged as lead candidates for so-called calorie restriction (CR) mimetics, agents that mimic the anti-cancer or anti-aging effects of CR without the restriction of dietary energy intake. This evidence concerns the gene MTOR and cancer.